Market Overview:
The global hydroxyapatite market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The medical grade hydroxyapatite (HAP) segment is expected to dominate the market during the forecast period, owing to its increasing demand for orthopaedic and dental applications. The research grade HAP segment is projected to grow at a higher CAGR than the medical grade HAP segment during the forecast period, as it is used in biochemical research applications. In terms of application, the orthopaedic application segment dominates the global hydroxyapatite market and is expected to continue its dominance during the forecast period. This can be attributed primarily due rising geriatric population across globe coupled with increasing incidence of bone fractures and osteoarthritis cases globally.
Product Definition:
Hydroxyapatite is a mineral formed from calcium and phosphate that is found in teeth and bones. Hydroxyapatite crystals are also responsible for the hard, crystalline structure of bones and teeth. Hydroxyapatite can also be used as a bone graft substitute to promote bone healing.
Medical Grade Hydroxyapatite (HAP):
Medical-grade hydroxyapatite (HAP) is a mineral that occurs naturally in the human body and is also commercially available. It has an amino acid called hydroxyapatite, which helps in repairing damaged cells and tissues. The main function of HAP is to help repair bone tissue by bringing new bone formation.
Research Grade Hydroxyapatite (HAP):
Research grade hydroxyapatite is a mineral that contains calcium, phosphate and hydrogen. It has the ability to replace lost bone mass due to disease or trauma which makes it an effective ingredient in the treatment of osteoporosis. The product also shows great potential in treating other diseases such as periodontal disease, arthritis and pain management owing to its anti-inflammatory properties.
Application Insights:
The orthopedic application segment led the global market in 2017. The growth of this segment can be attributed to the rising number of knee & hip replacement surgeries across the globe. As per WHO, around 1 million knee & hip replacement procedures are performed every year, globally. This is expected to boost product demand in near future.
Dental application is anticipated to witness significant growth over the forecast period owing to increasing tooth decay and gum diseases among children and youth worldwide including dental caries, periodontitis as well as tooth extraction cases. According to a study conducted by Centers for Disease Control and Prevention (CDC), it was observed that nearly 1 out of 3 children between 6-17 years have some form of dental cavities or problems related thereto, globally.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to continue its dominance over the forecast period. The presence of a large number of manufacturers coupled with increasing R&D activities in this region is anticipated to drive the APAC regional market. In addition, rising healthcare spending by consumers along with government support for building better hospitals & clinics are some factors driving demand for bone grafts and other products from this region.
The European market was valued at USD X million in 2017 and is projected to grow at a CAGR of XX% during the forecast period on account of growing application scope within biomedical research sector owing to high HAP availability as compared to synthetic hydroxyapatite (SHAP).
Growth Factors:
- Increasing demand from the medical industry for bone grafts and other medical applications
- Growing awareness of the benefits of hydroxyapatite among consumers
- Rising investments in research and development by hydroxyapatite manufacturers
- Expansion of distribution channels by hydroxyapatite suppliers
- Growing number of collaborations between hydroxyapatite producers and research institutes
Scope Of The Report
Report Attributes
Report Details
Report Title
Hydroxyapatite Market Research Report
By Type
Medical Grade Hydroxyapatite (HAP), Research Grade Hydroxyapatite (HAP)
By Application
Orthopaedic, Dental, Biochemical Research, Others
By Companies
SofSera, Fluidinova, Bio-Rad, Bonesupport AB, GE Healthcare, Sigma Graft, Berkeley Advanced Biomaterials, Zimmer Biomet, Nano Interface Technology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Hydroxyapatite Market Report Segments:
The global Hydroxyapatite market is segmented on the basis of:
Types
Medical Grade Hydroxyapatite (HAP), Research Grade Hydroxyapatite (HAP)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Orthopaedic, Dental, Biochemical Research, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- SofSera
- Fluidinova
- Bio-Rad
- Bonesupport AB
- GE Healthcare
- Sigma Graft
- Berkeley Advanced Biomaterials
- Zimmer Biomet
- Nano Interface Technology
Highlights of The Hydroxyapatite Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Medical Grade Hydroxyapatite (HAP)
- Research Grade Hydroxyapatite (HAP)
- By Application:
- Orthopaedic
- Dental
- Biochemical Research
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hydroxyapatite Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hydroxyapatite is a mineral that is composed of calcium and hydroxyl groups. It has a Mohs hardness of 5 to 6 and can be found in the form of crystals or as an amorphous material. Hydroxyapatite is used in medical devices, such as hip replacements, because it helps to resist wear and tear.
Some of the major players in the hydroxyapatite market are SofSera, Fluidinova, Bio-Rad, Bonesupport AB, GE Healthcare, Sigma Graft, Berkeley Advanced Biomaterials, Zimmer Biomet, Nano Interface Technology.
The hydroxyapatite market is expected to register a CAGR of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hydroxyapatite Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hydroxyapatite Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hydroxyapatite Market - Supply Chain
4.5. Global Hydroxyapatite Market Forecast
4.5.1. Hydroxyapatite Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hydroxyapatite Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hydroxyapatite Market Absolute $ Opportunity
5. Global Hydroxyapatite Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hydroxyapatite Market Size and Volume Forecast by Type
5.3.1. Medical Grade Hydroxyapatite (HAP)
5.3.2. Research Grade Hydroxyapatite (HAP)
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hydroxyapatite Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hydroxyapatite Market Size and Volume Forecast by Application
6.3.1. Orthopaedic
6.3.2. Dental
6.3.3. Biochemical Research
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hydroxyapatite Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hydroxyapatite Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hydroxyapatite Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hydroxyapatite Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hydroxyapatite Demand Share Forecast, 2019-2026
9. North America Hydroxyapatite Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hydroxyapatite Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hydroxyapatite Market Size and Volume Forecast by Application
9.4.1. Orthopaedic
9.4.2. Dental
9.4.3. Biochemical Research
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hydroxyapatite Market Size and Volume Forecast by Type
9.7.1. Medical Grade Hydroxyapatite (HAP)
9.7.2. Research Grade Hydroxyapatite (HAP)
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hydroxyapatite Demand Share Forecast, 2019-2026
10. Latin America Hydroxyapatite Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hydroxyapatite Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hydroxyapatite Market Size and Volume Forecast by Application
10.4.1. Orthopaedic
10.4.2. Dental
10.4.3. Biochemical Research
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hydroxyapatite Market Size and Volume Forecast by Type
10.7.1. Medical Grade Hydroxyapatite (HAP)
10.7.2. Research Grade Hydroxyapatite (HAP)
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hydroxyapatite Demand Share Forecast, 2019-2026
11. Europe Hydroxyapatite Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hydroxyapatite Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hydroxyapatite Market Size and Volume Forecast by Application
11.4.1. Orthopaedic
11.4.2. Dental
11.4.3. Biochemical Research
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hydroxyapatite Market Size and Volume Forecast by Type
11.7.1. Medical Grade Hydroxyapatite (HAP)
11.7.2. Research Grade Hydroxyapatite (HAP)
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hydroxyapatite Demand Share, 2019-2026
12. Asia Pacific Hydroxyapatite Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hydroxyapatite Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hydroxyapatite Market Size and Volume Forecast by Application
12.4.1. Orthopaedic
12.4.2. Dental
12.4.3. Biochemical Research
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hydroxyapatite Market Size and Volume Forecast by Type
12.7.1. Medical Grade Hydroxyapatite (HAP)
12.7.2. Research Grade Hydroxyapatite (HAP)
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hydroxyapatite Demand Share, 2019-2026
13. Middle East & Africa Hydroxyapatite Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hydroxyapatite Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hydroxyapatite Market Size and Volume Forecast by Application
13.4.1. Orthopaedic
13.4.2. Dental
13.4.3. Biochemical Research
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hydroxyapatite Market Size and Volume Forecast by Type
13.7.1. Medical Grade Hydroxyapatite (HAP)
13.7.2. Research Grade Hydroxyapatite (HAP)
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hydroxyapatite Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hydroxyapatite Market: Market Share Analysis
14.2. Hydroxyapatite Distributors and Customers
14.3. Hydroxyapatite Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. SofSera
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Fluidinova
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bio-Rad
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bonesupport AB
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. GE Healthcare
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Sigma Graft
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Berkeley Advanced Biomaterials
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Zimmer Biomet
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Nano Interface Technology
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
